Altered miRNA expression in T regulatory cells in course of multiple sclerosis

Journal of Neuroimmunology

Volumn 226, Issue 1-2, 2010, Pages 165-171

  De Santis, Giuseppe ^a,b   Ferracin, Manuela ^a   Biondani, Andrea ^a   Caniatti, Luisa ^a   Rosaria Tola, Maria ^a   Castellazzi, Massimiliano ^a   Zagatti, Barbara ^a   Battistini, Luca ^d   Borsellino, Giovanna ^d   Fainardi, Enrico ^c   Gavioli, Riccardo ^a   Negrini, Massimo ^a   Furlan, Roberto ^b   Granieri, Enrico ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Autoimmunity; MicroRNA; Multiple sclerosis; T regulatory cell; TGF beta

Indexed keywords

INTERLEUKIN 7 RECEPTOR; MICRORNA; TRANSFORMING GROWTH FACTOR BETA; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EFFECTOR CELL; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ANALYSIS OF VARIANCE; CLASSIFICATION; COCULTURE; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MICRORNAS; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956343824     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.06.009     Document Type: Article

References (41)

1. Baecher-Allan C., Hafler D.A. Suppressor T cells in human diseases. J. Exp. Med. 2004, 200:273-276.
2. Baecher-Allan C., Hafler D.A. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 2006, 212:203-216.
3. Baecher-Allan C., Viglietta V., Hafler D.A. Human CD4+CD25+ regulatory T cells. Semin. Immunol. 2004, 16:89-98.
4. Baecher-Allan C., Wolf E., Hafler D.A. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells. Clin. Immunol. 2005, 115:10-18.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
6. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
7. Boehm M., Slack F.J. MicroRNA control of lifespan and metabolism. Cell Cycle 2006, 5:837-840.
8. Bommireddy R., Engle S.J., Ormsby I., Boivin G.P., Babcock G.F., Doetschman T. Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice. Cell. Immunol. 2004, 232:96-104.
9. - naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003, 198:1875-1886.
10. Cobb B.S., Hertweck A., Smith J., O'Connor E., Graf D., Cook T., Smale S.T., Sakaguchi S., Livesey F.J., Fisher A.G., Merkenschlager M. A role for Dicer in immune regulation. J. Exp. Med. 2006, 203:2519-2527.
11. Compston A., Coles A. Multiple sclerosis. Lancet 2002, 359:1221-1231.
12. Davidson T.S., DiPaolo R.J., Andersson J., Shevach E.M. Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 2007, 178:4022-4026.
13. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 2004, 172:5149-5153.
14. Feger U., Luther C., Poeschel S., Melms A., Tolosa E., Wiendl H. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin. Exp. Immunol. 2007, 147:412-418.
15. Gartner D., Hoff H., Gimsa U., Burmester G.R., Brunner-Weinzierl M.C. CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progression. J. Neuroimmunol. 2006, 172:73-84.
16. Gorelik L., Flavell R.A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000, 12:171-181.
17. Hatfield S., Ruohola-Baker H. MicroRNA and stem cell function. Cell Tissue Res. 2008, 331:57-66.
18. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
19. Kulkarni A.B., Karlsson S. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 1993, 143:3-9.
20. Liston A., Lu L.F., O'Carroll D., Tarakhovsky A., Rudensky A.Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 2008, 205:1993-2004.
21. Love T.M., Moffett H.F., Novina C.D. Not miR-ly small RNAs: big potential for microRNAs in therapy. J. Allergy Clin. Immunol. 2008, 121:309-319.
22. Michel L., Berthelot L., Pettre S., Wiertlewski S., Lefrere F., Braudeau C., Brouard S., Soulillou J.P., Laplaud D.A. Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis. J. Clin. Invest. 2008, 118:3411-3419.
23. Negrini M., Ferracin M., Sabbioni S., Croce C.M. MicroRNAs in human cancer: from research to therapy. J. Cell Sci. 2007, 120:1833-1840.
24. Ostroukhova M., Seguin-Devaux C., Oriss T.B., Dixon-McCarthy B., Yang L., Ameredes B.T., Corcoran T.E., Ray A. Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J. Clin. Invest. 2004, 114:28-38.
25. Pauley K.M., Cha S., Chan E.K. MicroRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 2009.
26. Peng Y., Laouar Y., Li M.O., Green E.A., Flavell R.A. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl Acad. Sci. USA 2004, 101:4572-4577.
27. Petrocca F., Vecchione A., Croce C.M. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 2008, 68:8191-8194.
28. Rigby R.J., Vinuesa C.G. SiLEncing SLE: the power and promise of small noncoding RNAs. Curr. Opin. Rheumatol. 2008, 20:526-531.
29. Tang Q., Bluestone J.A. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 2006, 212:217-237.
30. Tibshirani R., Hastie T., Narasimhan B., Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl Acad. Sci. USA 2002, 99:6567-6572.
31. Venken K., Hellings N., Hensen K., Rummens J.L., Medaer R., D'Hooghe M.B., Dubois B., Raus J., Stinissen P. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J. Neurosci. Res. 2006, 83:1432-1446.
32. Venken K., Hellings N., Thewissen M., Somers V., Hensen K., Rummens J.L., Medaer R., Hupperts R., Stinissen P. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2008, 123:79-89.
33. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., Newman J., Bronson R.T., Crowley D., Stone J.R., Jaenisch R., Sharp P.A., Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132:875-886.
34. Viglietta V., Baecher-Allan C., Weiner H.L., Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199:971-979.
35. Xiao C., Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009, 136:26-36.
36. Yamagiwa S., Gray J.D., Hashimoto S., Horwitz D.A. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J. Immunol. 2001, 166:7282-7289.
37. - precursors. J. Immunol. 2002, 169:4183-4189.
38. - cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 2004, 172:5213-5221.
39. Zheng S.G., Wang J.H., Stohl W., Kim K.S., Gray J.D., Horwitz D.A. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol. 2006, 176:3321-3329.
40. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445:936-940.
41. Zhou X., Jeker L.T., Fife B.T., Zhu S., Anderson M.S., McManus M.T., Bluestone J.A. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 2008, 205:1983-1991.